V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30079426 | 30090106 | null | 91.95 | Palliative (P) | 2019-06-30 | 2019-06-30 | 111 Trial (formerly BEP 111) | 02 | null | CISPLATIN + VINORELBINE | 101793962 |
| 30122561 | 30091048 | 1.74 | 79 | null | 2020-01-24 | 2020-01-24 | 111 Trial (formerly BEP 111) | 02 | N | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 100315075 |
| 30122851 | 30091057 | 1.76 | 94.1 | Curative (C) | 2020-09-26 | 2020-10-08 | 111 Trial (formerly BEP 111) | 02 | null | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 101671833 |
| 30138355 | 30091334 | 1.85 | 65 | Palliative (P) | null | 2017-05-28 | 111 Trial (formerly BEP 111) | 02 | N | IVA | 100951576 |
| 30174040 | 30091946 | 1.68 | 71 | Curative (C) | 2018-05-02 | 2018-05-09 | 111 Trial (formerly BEP 111) | 02 | null | ERLOTINIB | 101642481 |
| 80048334 | 80050052 | 1.78 | 81.4 | Adjuvant (A) | 2019-03-06 | 2019-03-06 | A-PREDICT TRIAL | N | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100969075 |
| 80043022 | 80047622 | 1.64 | 13.3 | null | 2019-02-08 | 2019-02-11 | A-PREDICT TRIAL | N | N | ENZALUTAMIDE | 101109149 |
| 70074809 | 70099999 | 1.4 | 55.3 | Curative (C) | 2017-12-20 | 2018-03-12 | A2G trial Asparaginase | 02 | N | NOT MATCHED | 100164790 |
| 70079038 | 70181751 | null | null | Curative (C) | 2019-05-11 | 2019-08-30 | A2G trial Asparaginase | 02 | N | NOT MATCHED | 101529921 |
| 70075281 | 70155977 | 1.54 | 58.5 | Neo-adjuvant (N) | 2017-10-09 | 2017-11-12 | A2G trial Asparaginase | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 101493128 |
| 70074961 | 70155874 | 1.71 | null | null | 2018-11-19 | 2018-11-22 | A2G trial Asparaginase | 02 | null | NOT MATCHED | 100030200 |
| 70073943 | 70133010 | 1.69 | 57.25 | 03 | 2019-11-12 | 2019-11-15 | A2G trial Asparaginase | 02 | N | BRENTUXIMAB | 101802289 |
| 20152813 | 20087841 | 1.73 | 84.7 | Adjuvant (A) | 2021-02-04 | 2021-02-20 | ABC-08 Trial | 02 | N | ACELARATE TRIAL | 100598057 |
| 20108852 | 20087195 | 1.82 | 96 | 03 | 2019-02-02 | 2019-03-01 | ABC-08 Trial | 02 | N | CABAZITAXEL | 100885043 |
| 20055534 | 20086641 | 1.67 | 76 | Palliative (P) | 2019-03-31 | 2019-04-16 | ABC-08 Trial | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100077497 |
| 20029260 | 20085737 | 1.58 | 53.6 | Palliative (P) | 2017-11-05 | 2017-11-07 | ABC-08 Trial | N | N | PAZOPANIB | 100332183 |
| 40162821 | 40197265 | 1.64 | 75.8 | Palliative (P) | 2020-01-31 | 2020-03-15 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101647223 |
| 40166034 | 40250111 | 1.74 | 63 | null | 2017-01-19 | 2017-02-10 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100894350 |
| 40169506 | 40316449 | 1.56 | 99 | null | 2020-10-06 | 2020-10-14 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101376458 |
| 40167659 | 40282038 | 1.65 | 74.9 | null | 2019-02-22 | 2019-02-23 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101226279 |
| 40166719 | 40281679 | 1.61 | 61.2 | null | 2019-12-24 | 2020-01-18 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100493032 |
| 40162209 | 40196908 | 1.67 | 84 | null | 2022-05-01 | 2022-05-09 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100267350 |
| 40162194 | 40196899 | 1.62 | 76.1 | null | 2021-07-24 | 2021-07-26 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101684738 |
| 40162159 | 40196882 | 1.77 | 71.5 | Palliative (P) | 2021-10-10 | 2022-02-18 | ABEMACICLIB + FULVESTRANT | 99 | N | ABEMACICLIB + FULVESTRANT | 100206439 |
| 40162162 | 40196885 | 1.52 | 97 | null | 2019-02-26 | 2019-03-05 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100548875 |
| 40162184 | 40196896 | 1.68 | 97 | null | 2022-04-25 | 2022-05-03 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101620056 |
| 40162200 | 40196902 | 0 | 0 | null | 2018-05-03 | 2018-05-03 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101525391 |
| 40162201 | 40196903 | 1.6 | 50 | null | 2021-09-30 | 2021-10-01 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100407034 |
| 40162204 | 40196905 | 1.6 | 50 | null | 2019-08-09 | 2019-09-03 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100366307 |
| 40162131 | 40196865 | 1.7 | 50.2 | Palliative (P) | 2019-10-04 | 2019-10-05 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 100921004 |
| 40162216 | 40196913 | 0 | 0 | null | 2019-08-13 | 2019-09-02 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100240589 |
| 40162223 | 40196917 | 1.68 | 73.2 | null | 2017-07-04 | 2017-07-04 | ABEMACICLIB + FULVESTRANT | null | null | ABEMACICLIB + FULVESTRANT | 100913143 |
| 40026177 | 40122168 | null | 106 | Adjuvant (A) | null | 2018-01-15 | ABEMACICLIB + FULVESTRANT | 99 | N | ABEMACICLIB + FULVESTRANT | 101076072 |
| 40162020 | 40196794 | 1.5 | 101 | null | 2020-03-19 | 2020-03-23 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100668676 |
| 40027871 | 40122211 | 1.58 | 97.8 | Neo-adjuvant (N) | 2020-01-19 | 2020-01-19 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101451338 |
| 40002025 | 40121626 | 0 | 112.1 | Palliative (P) | 2021-07-24 | 2021-08-11 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100991378 |
| 40162037 | 40196803 | 1.6 | 72.1 | Palliative (P) | 2021-01-14 | 2021-01-29 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 100258950 |
| 40162146 | 40196875 | 1.51 | 89 | null | 2018-06-27 | 2018-06-27 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101302765 |
| 40162135 | 40196868 | 1.54 | 105.4 | null | 2021-12-03 | 2021-12-22 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101668502 |
| 40168861 | 40120963 | 1.55 | 81.2 | Neo-adjuvant (N) | 2018-03-15 | 2018-03-29 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 100217102 |
| 40162124 | 40196861 | 1.5 | 71.3 | Palliative (P) | 2021-09-30 | 2021-10-17 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 100471099 |
| 40162098 | 40196843 | 1.6 | 95.8 | Palliative (P) | 2019-09-22 | 2019-09-29 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101019193 |
| 40162094 | 40196840 | 1.57 | 65 | Palliative (P) | 2020-03-16 | 2020-03-16 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 100463208 |
| 70073308 | 70163053 | 1.76 | 110.4 | null | 2020-06-23 | 2020-07-06 | ABEMACICLIB + FULVESTRANT | 02 | N | IRINOTECAN + MDG | 100139185 |
| 90066928 | 90031078 | 0 | 63.8 | Palliative (P) | 2016-10-29 | 2016-11-23 | ABEMACICLIB + FULVESTRANT | N | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101296726 |
| 40162084 | 40196833 | 1.69 | 82.2 | null | 2021-03-30 | 2021-04-12 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100816085 |
| 40162047 | 40196812 | 1.71 | 95.8 | Palliative (P) | 2020-12-29 | 2021-01-12 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101389353 |
| 40162044 | 40196810 | 1.54 | 97 | null | 2022-02-10 | 2022-03-02 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100576470 |
| 40001373 | 40121611 | 0.65 | 63.9 | null | 2021-06-25 | 2021-07-12 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101495115 |
| 40162147 | 40196876 | 1.62 | 70.4 | 03 | 2022-03-23 | 2022-03-23 | ABEMACICLIB + FULVESTRANT | 99 | N | ABEMACICLIB + FULVESTRANT | 100813242 |